Factors associated with chloroquine-induced retinopathy in rheumatic diseases

Lupus - Tập 13 Số 2 - Trang 119-124 - 2004
Rodolfo Araiza-Casillas1, Maria Cardenas2, Y Morales2, Mario H. Cardiel1
1Department of Immunology and Rheumatology; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Mexico DF, Mexico
2Department of Opthalmology

Tóm tắt

Antimalarials are very useful drugs in the treatment of various rheumatic diseases. One of their main side effects is ocular toxicity, specifically retinopathy. Our objective was to identify risk factors associated with chloroquine retinopathy. A single, trained evaluator reviewed patient records with rheumatic diseases. They were taking chloroquine and identified by the ophthalmologydepartment as having retinopathy during their routine eye evaluation. These cases were classified according to clinical evaluation, visual fields and fluorangiographic study. Up to four controls were selected for each case, matched by age, gender, diagnosisand similar time on chloroquine.In all, 34 variableswere studied, among these: weight, age, disease duration, keratopathy, total cumulative dose (TCD), mean daily dose (MDD), lean body weight adjusted daily dose (LBWDD) and laboratory tests. Descriptive and inferential statistics comparing cases and controls in all patients and subgroup analysis were carried out. Significance was set at the 0.05 level. Odds ratio and 95% confidence intervals were calculated. Sixteen cases of chloroquine retinopathy were identified, eight patients with rheumatoid arthritis (RA), seven with systemic lupus erythematosus (SLE) and one with dermatomyositis. All were female. Mean age was 47.3 + 12.2 years; weight 59.5 + 10.7 kg; disease duration 12.8 + 6.0 years; time on chloroquine 54.1 + 27.8 (min-max: 30-197) months. There was a significant difference in the following variables in all patients: MDD 212.3 + 52.6 versus 170 + 51.3, p 0.009; and LBWDD 5 + 1 versus 4.2 + 1.5, p 0.03, for cases and controls, respectively. In subgroup analysis the MDD remained significantly different (235.5 + 45.8 versus 169.7 + 46.l, p 0.004) only in RA, whereas LBWDD was different both in SLE and RA. Keratopathy increased the risk for retinopathy: OR, 95% CI: 5, 1.4-l7.6, p 0.01. In conclusion, in accordance with previous studies, the MDD, LBWDD and keratopathy were risk factors associated with chloroquine retinopathy. Periodic ophthalmologic evaluations are mandatory.

Từ khóa


Tài liệu tham khảo

Urbina JH, 1996, Rev Esp Rheumatic, 23, 418

Ryes RI., 1997, B J Rheumatol, 36, 799, 10.1093/rheumatology/36.7.799

Olson NY, 1989, J Rheumatol, 16, 1545

Fox RI, 1996, Lupus, 5, S3l

10.1177/096120339600500313

Fries JF, 1993, Arthritis Rheum, 36, 297, 10.1002/art.1780360303

Felson DT, 1990, Arthritis Rheum, 33, 1449, 10.1002/art.1780331001

Maksymwych W, 1987, Semin Arthritis Rheum, 16, 206, 10.1016/0049-0172(87)90023-0

Easterbrook M., 1999, J Rheumatol, 26, 1866

Brinkley JR, 1979, Am J Ophthalmol, 88, l, 10.1016/0002-9394(79)90743-8

Ogawa S, 1979, Lancet, 30, 1408, 10.1016/S0140-6736(79)92044-0

Elman A, 1976, Scan J Rheumatol, 5, 161, 10.3109/03009747609165456

Nylander V., 1966, Acta Ophthalmol, 44, 335, 10.1111/j.1755-3768.1966.tb08039.x

Arden G, 1966, Br Med J, 1, 270, 10.1136/bmj.1.5482.270

Marks JS., 1982, Ann Rheum Dis, 41, 52, 10.1136/ard.41.1.52

Bernstein HN., 1983, Am J Med, 75, 25, 10.1016/0002-9343(83)91267-6

Easterbrook M., 1987, J Rheumatol, 14, 472

Mackenzie AH., 1983, Am J Med, 75, 40, 10.1016/0002-9343(83)91269-X

Koehler B., 1997, J Rheumatol, 24, 1393

Dubois EL., 1978, Semin Arthritis Rheum, 8, 33, 10.1016/0049-0172(78)90033-1

Rynes RI, 1979, Arthritis Rheum, 22, 833, 10.1002/art.1780220805

Tobin D, 1982, Arch Ophthalmol, 100, 81, 10.1001/archopht.1982.01030030083006

Voipio H., 1966, Acta Ophthalmol, 44, 349, 10.1111/j.1755-3768.1966.tb08040.x

Easterbrook M., 1988, Am J Med, 85, 23, 10.1016/0002-9343(88)90358-0

Cullen AP, 1986, J Am Optom Assoc, 57, 368

Easterbrook M., 1990, Can J Ophthalmol, 25, 249

Mavrikakis I, 2003, Ophthalmology, 110, 1321, 10.1016/S0161-6420(03)00409-3

Aviña-Zubieta JA, 1998, Ann Rheum Dis, 57, 582, 10.1136/ard.57.10.582

Thông tin
Thông tin xuất bản

Lupus

Tập 13 Số 2

119-124

Thông tin tác giả